In Human Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Anteris Technologies Reports Positive 30-Day Results from First-In-Human Study

Anteris Technologies Reports Positive 30-Day Results from First-In-Human Study
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Wayne patersonAnteris technologiesIn human study

Anteris Technologies Ltd presents first-in-human data at conference showing excellent haemodynamic performance

Anteris Technologies Ltd presents first-in-human data at conference showing excellent haemodynamic performance
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesWayne patersonAnteris technologies ltdTranscatheter valve therapyNew york heart classIn human studyChris meduri

Mineralys Therapeutics Presents Positive Lorundrostat Results from the Phase 2 Target-HTN Trial at ACC 23/WCC

Mineralys Therapeutics Presents Positive Lorundrostat Results from the Phase 2 Target-HTN Trial at ACC 23/WCC
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDavid rodmanJon congletonCatalys pacificLuke laffinAmerican college of cardiologyMedia relationstom weibleelixir health public relationsphoneMineralys therapeutics incExchange commissionVascular thoracic instituteWorld congressAmerican collegeAnnual scientific sessionNew orleansChief executive officerEffective blood pressure lowering

Mineralys Therapeutics Presents Positive Lorundrostat

Lorundrostat demonstrated clinically meaningful blood pressure reduction in individuals with uncontrolled hypertension Obesity was predictive of an.

United statesDavid rodmanJon congletonCatalys pacificLuke laffinTom weibleAmerican college of cardiologyMineralys therapeutics incExchange commissionVascular thoracic instituteElixir health public relationsWorld congressAmerican collegeAnnual scientific sessionNew orleansChief executive officer